Loading clinical trials...
Loading clinical trials...
A Before/After Study of the Impact of Quantitative Neuromuscular Monitoring and Sugammadex Reversal Following Gastric Bypass Surgery
Conditions
Interventions
Quantitative Neuromuscular Function Monitoring
Locations
1
United States
UC Davis Medical Center
Sacramento, California, United States
Start Date
February 8, 2023
Primary Completion Date
July 1, 2025
Completion Date
July 1, 2025
Last Updated
May 15, 2025
NCT06962007
NCT06623370
NCT05708469
NCT04997759
NCT05066035
NCT02025309
Lead Sponsor
University of California, Davis
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions